Cooper Creek Partners Management LLC Assembly Biosciences, Inc. Transaction History

Cooper Creek Partners Management LLC

  • $2.99 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020
SELL
$8.36 - $23.81 $1.99 Million - $5.67 Million
-238,178 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$9.83 - $14.82 $2.34 Million - $3.53 Million
238,178 New
238,178 $2.34 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Cooper Creek Partners Management LLC Portfolio

Follow Cooper Creek Partners Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Creek Partners Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Creek Partners Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email